phosphorus has been researched along with mk-0524 in 2 studies
Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (mk-0524) | Trials (mk-0524) | Recent Studies (post-2010) (mk-0524) |
---|---|---|---|---|---|
48,074 | 1,126 | 17,139 | 121 | 57 | 71 |
Protein | Taxonomy | phosphorus (IC50) | mk-0524 (IC50) |
---|---|---|---|
Prostaglandin D2 receptor | Homo sapiens (human) | 0.0007 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bostom, AG; Hanlon, WA; Kuznetsova, O; Maccubbin, D; Tipping, D | 1 |
Bostom, A; Ix, JH; Rao, M; Steffes, M | 1 |
2 trial(s) available for phosphorus and mk-0524
Article | Year |
---|---|
Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.
Topics: Aged; Biomarkers; Calcium; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Hypolipidemic Agents; Hypophosphatemia; Indoles; Kidney Diseases; Male; Middle Aged; Niacin; Phosphorus; Receptors, Immunologic; Receptors, Prostaglandin; Severity of Illness Index; Time Factors | 2010 |
Effect of niacin on FGF23 concentration in chronic kidney disease.
Topics: Aged; Calcium; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypolipidemic Agents; Indoles; Male; Middle Aged; Niacin; Parathyroid Hormone; Phosphorus; Receptors, Immunologic; Receptors, Prostaglandin; Renal Insufficiency, Chronic | 2014 |